Dr Harpreet Wasan

Dr Harpreet Wasan leads the gastrointestinal clinical research programme at Hammersmith Hospital, Imperial College London. He is on the UK National Cancer Research Institute steering committee of both the advanced colorectal cancer and upper gastrointestinal groups, as well as the inaugural chair of the West London Cancer Network.

Dr Wasan is involved in the Trial management of many CRC studies including one of the largest metastatic colorectal cancer studies in the world (COIN study), and the chief investigator (CI) in its sub-study (COIN-B), as well as a co-investigator on the largest prospective study in chemotherapy in the elderly (FOCUS-2) which reports in 2007. He is on the European working party on CRC liver metastases guidance.

In upper gastrointestinal cancer he is Co-PI and PI in the UK NRCN trials portfolio in advanced Biliary cancer and Cancer of unknown primary, with the latter two designed to be the largest studies of their kind in the world. He is a fellow of the Royal College of Physicians and the Oncology advisor to the UK Drugs and Therapeutics Bulletin (DTB) amongst many other national consultative roles.

Clinical Interests

• Gastrointestinal malignancy
• Genitourinary malignancy (bladder, prostate, kidney, testicular)
• Lymphomas
• Experimental new therapies
• Screening for cancer and genetic predisposition to cancer.

Current NHS and /or University Posts

• Consultant Oncologist, Hammersmith Hospital

Useful Links

• Harpreet Wasan Linkedin profile

Professional Memberships

• Member of the Royal College of Physicians
• Member of General Medical Council